CBWD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.756600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.897000E-01
Normal-vs-Stage2
4.006200E-01
Normal-vs-Stage3
8.660400E-01
Normal-vs-Stage4
2.666000E-01
Stage1-vs-Stage2
9.068800E-01
Stage1-vs-Stage3
2.394800E-01
Stage1-vs-Stage4
6.040600E-01
Stage2-vs-Stage3
2.615400E-01
Stage2-vs-Stage4
4.672400E-01
Stage3-vs-Stage4
2.146000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.750600E-01
Normal-vs-AfricanAmerican
2.826000E-01
Normal-vs-Asian
5.406000E-01
Caucasian-vs-AfricanAmerican
8.261000E-01
Caucasian-vs-Asian
6.453200E-01
AfricanAmerican-vs-Asian
9.061600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.831400E-01
Normal-vs-Female
3.838200E-01
Male-vs-Female
8.423000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.938200E-01
Normal-vs-Age(41-60Yrs)
3.330800E-01
Normal-vs-Age(61-80Yrs)
4.471200E-01
Normal-vs-Age(81-100Yrs)
2.049400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.028800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.499000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.454600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.308400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.688000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.432800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.566400E-01
Normal-vs-Daily Drinker
5.293400E-01
Normal-vs-Weekly Drinker
2.789600E-01
Normal-vs-Occasional Drinker
2.431200E-01
Normal-vs-Social Drinker
3.333600E-01
Non Drinker-vs-Daily Drinker
9.725800E-01
Non Drinker-vs-Weekly Drinker
1.359770E-01
Non Drinker-vs-Occasional Drinker
5.893600E-02
Non Drinker-vs-Social Drinker
4.393200E-01
Daily Drinker-vs-Weekly Drinker
1.323170E-01
Daily Drinker-vs-Occasional Drinker
8.602300E-02
Daily Drinker-vs-Social Drinker
4.197400E-01
Weekly Drinker-vs-Occasional Drinker
9.304800E-01
Weekly Drinker-vs-Social Drinker
3.310600E-01
Occasional Drinker-vs-Social Drinker
3.247600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.330200E-01
Normal-vs-Grade 2
9.049400E-01
Normal-vs-Grade 3
9.276400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.174000E-01
Grade 1-vs-Grade 3
9.772200E-02
Grade 1-vs-Grade 4
8.330200E-01
Grade 2-vs-Grade 3
6.581400E-01
Grade 2-vs-Grade 4
9.049400E-01
Grade 3-vs-Grade 4
9.276400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.074400E-01
Normal-vs-NonDiabetic
4.243000E-01
Diabetic-vs-NonDiabetic
4.407400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.957200E-01
Normal-vs-NoPancreatitis
3.432400E-01
Pancreatitis-vs-NoPancreatitis
5.221100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.683000E-01
Normal-vs-N1
4.175400E-01
N0-vs-N1
3.872000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.998380E-01
Normal-vs-TP53-NonMutant
1.723380E-01
TP53-Mutant-vs-TP53-NonMutant
3.447600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
